Oxyphenbutazone in the treatment of acute ureteral stone disease.

Abstract	A comparative study between the effect of oxyphenbutazone and placebo in acute ureteral disease was carried out in 45 patients. The results are statistically significant in favour of the group treated with oxyphenbutazone with respect to the rapidity and the incidence of spontaneous passage of ureteral stones.
Authors	A Nygård, S Bjorneby
Journal	Scandinavian journal of urology and nephrology (Scand J Urol Nephrol) Vol. 9 Issue 1 Pg. 36-8 ( 1975) ISSN: 0036-5599 [Print] England
PMID	766157 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References	Placebos Oxyphenbutazone
Topics	Acute Disease Clinical Trials as Topic Drug Evaluation Humans Oxyphenbutazone (administration & dosage, therapeutic use) Placebos Time Factors Ureteral Calculi (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!